Clinical Trials Directory

Trials / Completed

CompletedNCT06410027

Effects of Pain Neuroscience Education and Virtual Reality in Patients With Chronic Low Back Pain

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Universidad de Granada · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The objective of our study is to evaluate the effects of a therapeutic intervention including 1-hour of pain neuroscience education session, 30-minutes of exposure to exercise with virtual realit and therapeutic exercise in patients with chronic low back pain.

Detailed description

Chronic low back pain is the world's leading cause of years of life lived with disability. Negative thoughts and beliefs about pain experienced can lead to pain avoidance behaviours. Fear of movement is a common behaviour in this type of patients and is associated with avoidance of exercise. Virtual reality is a powerful distraction technique as it directs the patient's attention to an external stimulus rather than pain or body movement. Therefore, it can be beneficial to avoid some pain-related problems, such as kinesiophobia and inactivity. Moreover, pain neuroscience education aim to reconceptualise pain perceptions, beliefs, and avoidance behaviours. Then, the use of these interventions may be beneficial in the treatment of patients with chronic low back pain. The objective of this study is to evaluate the effects of a therapeutic intervention using pain neuroscience education and virtual reality in patients with chronic low back pain.

Conditions

Interventions

TypeNameDescription
OTHERPain Neuroscience Education + Virtual Reality + Therapeutic ExercisePatients will receive 1-hour pain neuroscience education session + 30-minutes exposure to exercise with virtual reality + therapeutic exercise
OTHERTherapeutic ExercisePatients will receive therapeutic exercise

Timeline

Start date
2024-04-20
Primary completion
2025-01-31
Completion
2025-01-31
First posted
2024-05-10
Last updated
2026-01-27

Locations

2 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT06410027. Inclusion in this directory is not an endorsement.